We are proud to have worked with Stemedica since 2015 as a trusted partner distributing its ischemic-tolerant stem cell products to its wide client base within the research community. Stemedica has now evolved to the point where it is conducting a Phase II clinical trial and we are very pleased to scale our agreement with them to support their work fighting Alzheimer's disease." Cryoport currently supports more than 78 clinical trials worldwide. The Company's clinical trial clients include ImmunoCellular Therapeutics, Kite Pharma, Gradalis and Perseus PCI. About Stemedica Cell Technologies, Inc. Stemedica Cell Technologies, Inc. is a global biopharmaceutical company that manufactures best-in-class allogeneic adult stem cells and stem cell factors.